Results 191 to 200 of about 828,864 (314)

Patients' Perceptions of Kidney Transplant Failure and Return to Dialysis. [PDF]

Kidney Med
Ramos E, Bonnet KR, Schlundt D, Gu C, Hanson C, Gordon EJ, Concepcion BP.   +6 more
europepmc   +1 more source

Mesenchymal Stromal Cell‐Based Cell–Drug Conjugates for the Treatment of Acute Liver Failure

Advanced Science, EarlyView.
Mesenchymal stromal cell (MSC)‐based cell‐drug conjugates are constructed by anchoring rosiglitazone‐loaded nanoparticles onto the MSC surface. Sustained rosiglitazone release enhances MSC proliferation and paracrine activity while promoting anti‐inflammatory macrophage polarization.
Tenghui Ye, Jiamin Wu, Zixin Wu, Xi Liu, Jiajia Luo, Leyi Yang, Peng Shi   +6 more
wiley   +1 more source

Peritoneal Dialysis-Related Peritonitis and Kidney Transplant Outcomes.

JAMA Netw Open
Jiang N, Tunbridge M, Ryan EG, Gately R, Green S, Walker R, Johnson DW, Cho Y.   +7 more
europepmc   +1 more source

Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant Recipients. [PDF]

Ann Transplant
Górska M, Wróbel F, Rząsa M, Kurnatowska I.   +3 more
europepmc   +1 more source

Oral Nanomicelle‐Mediated Sequential Butyrate Production in the Intestine for Ulcerative Colitis and Immunosuppression Treatment

Advanced Science, EarlyView.
After oral administration, inodorous GLU‐BA self‐assembles into nanomicelles in aqueous environments to resist premature gastric adsorption. Upon reaching the intestine, endogenous esterases rapidly cleave the built‐in ester bonds in these nanomicelles to release BA and GLU, with GLU further metabolized by gut microbiota to gradually generate BA ...
Feifei Xin, Zhike Xie, Danyue Zhao, Lin Yang, Yiqun Wan, Zuwei Liu, Situ Xiong, Ying Zhang, Lei Feng, Hao Wan   +9 more
wiley   +1 more source

Antidiscrimination Laws and Kidney Transplant for Patients With Developmental Disabilities.

JAMA Intern Med
Hand BN, Hyer JM, Nikahd M, Gothard A, Brock G, Gardner J, Bishop L, Shea L, Wang L, Schenk AD.   +9 more
europepmc   +1 more source

A BSCB‐Penetrating Nanoplatform for Enhanced Luteolin Delivery in PRMT2‐Targeted Epigenetic Therapy of Spinal Cord Injury

Advanced Science, EarlyView.
In this work, MSN‐BO@LUT penetrates the blood‐spinal cord barrier for luteolin delivery in spinal cord injury. The nanodrug suppresses neuroinflammation and promotes functional recovery of the spinal cord. Mechanistically, luteolin targets protein arginine N‐methyltransferase (PRMT2) to decrease toll‐like receptor 4 (TLR4) methylation, thereby ...
Yixuan Wang, Bo Jin, Shipian Li, Qianxi Ouyang, Yu Xiao, Jiaxin Wen, Yehua Lai, Ping Wang, Yongjun Wang, Xuejun Cui, Weian Zhang, Min Yao   +11 more
wiley   +1 more source

WCN24-2479 Minocycline-induced Drug sensitivity syndrome with eosinophilia and systemic symptoms (Dress) with development of severe acute interstitial nephritis

Kidney International Reports
Luz Bendersky, Nadia Marlen Ortiz, Vanesa Alejandra Fauda, Ana Lucía Saez, Claudia Yeneris, Ivanna Gardarian, Rocío Busolo, Cenith Contrera, Verónica Solernu, Natalia Salazar, Marcos Paz, Silvina Steinbrun, Juan Ibañez, Marta Adragna   +13 more
doaj   +1 more source

Early Onset Bacteremia in Kidney Transplant Recipients in the Current Era. [PDF]

Transpl Infect Dis
Hasan L, Shrestha NK, Duck M, Augustine J, Fatica R, Wee A, Koval CE.   +6 more
europepmc   +1 more source

14‐3‐3γ Protects Against Postoperative Cognitive Dysfunction by Regulating Tau Thr205 Phosphorylation and Synaptic Integrity

Advanced Science, EarlyView.
Integrative multi‐cohort analyses identify 14‐3‐3γ as a biomarker and regulator of cognitive vulnerability. Experimental studies show that 14‐3‐3γ loss is associated with Tau Thr205 phosphorylation, synaptic dysfunction, and cognitive impairment, while genetic overexpression or pharmacological stabilization of 14‐3‐3γ confers protective effects in ...
Shouqiang Zhu, Xue Han, Heng Zhang, Chang Ye, Tianjiao Xia, Xiaoping Gu   +5 more
wiley   +1 more source